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Abstract
Genome editing has become an important tool in identifying the specific function 
and role of a gene in an organism. With the advent of genome editing using clustered 
regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated (Cas) 
systems, editing a gene has become much easier and less expensive. This CRISPR/Cas9 
system uses a small 20 nucleotide long guided RNA (gRNA), which along with Cas9 will 
bind to the target site and cleave it. In this research, CRISPR/Cas9 system was used to 
knock out the inducible cAMP early repressor (ICER) promoter sequence in zebra fish. 
ICER has anti-proliferative activity and acts as a tumor suppressor. In Ras-induced 
melanoma, ICER protein is being targeted to degradation. Knocking out the ICER gene 
will help us to establish the tumorigenicity of ICER in melanomas.
A gRNA, specific towards the ICER promoter sequence was designed in an 
attempt to cleave it with Cas9. Plasmids pDR274(-)atgICER and pMLM3613 were used 
to generate gRNA and Cas9mRNA via in vitro transcriptions. To check the efficiency of 
designed gRNA in vitro, PAC-2 cell lines were transfected with a plasmid that expressed 
both gRNA and Cas9. The results demonstrate the ability of Cas9 to cleave the target 
sequence. In the future, this plasmid could be used to perform microinjection in zebra fish 
embryos with the generated gRNA and Cas9mRNA.
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Introduction
A critical role in biology is to determine the function of each gene \  Gene editing 
is one fascinating tool that enables us to study and determine the function of an individual 
gene in an organism. Earlier, gene functions were determined using forward genetics 
screening methods like chemical mutagenesis and transposon mediated mutagenesis 2’3. 
Even though these methods were initially successful, each had its own procedure to 
determine the mutated site and the whole process is laborious and time consuming 4.
With the advent of new and affordable sequencing methods, the complete genome 
sequence of an organism is more readily available. This led to the study of specific gene 
function using reverse genetics techniques. Some of the reverse genetics techniques 
include 1) partial gene knock down by R N A i5’6, 2) virus induced gene silencing 7, 3) 
insertional mutagenesis and 4) chemical mutagenesis/ targeted induced local lesions in 
genomes (TILLING). All of these methods have some limitations. For example, gene 
silencing using RNAi has unpredictable off targets and the result varies between 
experiments 8' 6. Methods like TILLING need large mutant populations and are expensive 
. The demand for more precise study on genes and their functions, led to the 
development of new gene editing techniques, which are more effective and less 
expensive.
In the past decade, a new genome editing approach emerged that enabled a gene 
to be edited using engineered nucleases 2? 6? 9. This approach relies on DNA repair that 
occurs when a double stranded DNA is cleaved. The two main types of DNA repair 
mechanism to repair double stranded breaks are non-homologous end joining method 
(NHEJ) and homologous recombination repair (H R )2. Non-homologous end joining
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repair could result in nucleotide insertion or deletion (indels), which in turn may affect 
the gene function 10. The genome editing tools like zinc finger nucleases (ZFNs) and 
transcription activator-like effector nucleases (TALENs) cut the DNA at specific sites 
and stimulate DNA repair mechanisms such as, NHEJ repair and HR, allowing study of 
gene function 6.
Zinc finger nucleases are a combination of a zinc finger domain and Fkol 
nucleases. Zinc finger domains are a small yet common motif observed in proteins, 
especially in DNA binding proteins 6. A different Zinc finger domain binds to a different 
nucleotide triplet in the major groove of the DNA. This nucleotide specificity of this zinc 
finger domain along with the nucleases Fkol allows precise cleavage within the target 
gene. Even though this method was successful, it had a few limitations, a) the 
corresponding zinc finger domains have not been discovered for all nucleotide triplets, b) 
production of zinc finger nuclease is highly labor intensive, time-consuming and very 
expensive 6.
Like ZFNs, another effective tool for genome editing with relatively rare off 
target effect is TALENs. TALEN is a combination of TALE and Fkol nuclease. TALE 
(transcription activator-like effector) was first discovered in plant pathogens 
Xanthomonas s p 2 and it has a DNA binding domain with 30 -35 tandem amino acid 
repeats that recognize a single, specific nucleotide in DNA 2’8. The amino acid residues 
within this repeats are highly conserved and changes within these amino acid residues 
contributes to its different binding specificity. The successful outcome in gene editing 
using TALE depends on the tandem repeats. At the same time, constructing a TALE with 
many repeats is laborious and time consuming.
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In spite of the site specific cleavage achieved using the above ZFNs and TALENs, 
the discovery of type II CRISPR/Cas system emerged as a more efficient gene editing 
tools. This CRISPR/Cas system, also called the RNA guided nucleases genome editing 
tool, has been proven to be very simple, cost effective, less time-consuming and can be 
applied on all organisms n ’12,13,14. In this system, a small piece of processed RNA guides 
Cas nuclease to specifically cleave the DNA to which it binds.
Type II CRISPR/Cas system is an adaptive immune mechanism used by many 
bacteria against invading pathogens, especially viruses 15,16,17. In this process, bacteria 
incorporates a short sequence of a genetic element from the invading pathogen into its 
genome, at a unique site called the clustered regularly interspaced short palindromic 
repeats or CRISPR loci. This CRISPR is composed of short tandem repeats of 
approximately 30-40 base pairs (bp). The sequence from the invading pathogen called the 
spacer/protospacer is incorporated between the CRISPR repeats 18,19,20. Following an 
attack, the CRISPR responds to the invading pathogen, by transcribing and processing the 
protospacer sequence at the CRISPR locus to produce CRISPR RNA (crRNA).The 
crRNA consists of the sequence from the invading pathogen and it is flanked by part of 
the CRISPR repeat. This crRNA hybridizes with the trans-activating RNA (tracrRNA) 
and forms a complex with the Cas9 protein (Cas9 protein contains RuvC nucleases and 
HNH nuclease domain). The crRNA then binds to its complementary target DNA and 
directs Cas9 nuclease to cleave the DNA-1, 22. Overall, genome editing using 
CRISPR/Cas9 requires only two components: a small crRNA specific towards the target 
site and a Cas9 enzyme to cleave the target site. This eliminates the complication of
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designing multiple zinc fingers as required by ZFNs and repetitive amino acid sequence 
as required by TALENs at target site 23,24.
Researchers have used this CRISPR/Cas system from Streptococcus pyogenes 
(S.pyogenes) to edit the genome in recent years. This was done by expressing the Cas9 
protein and a small guided RNA called gRNA (a fusion between crRNA and tracrRNA) 
complementary to the target DNA that is to be cleaved. Recent in vitro and in vivo studies 
have successfully employed this mechanism in a few model organisms like zebra fish, 
fruit flies, and mice ’11,25. The only constraints with this system are: the size of the 
gRNA should be 20 nucleotides long and the target site should be immediately followed 
by a protospacer adjacent motif called PAM. The PAM sequence is necessary for gRNA 
to direct Cas9 to cleave the target DNA 21,26,21. The most recognized PAM sequence is 
5’-NGG-3’. Sometimes a PAM site with 5’-NGA-3’ is also recognized, but with less 
efficiency. Thus, Cas9 protein could be directed to cleave any DNA site in the form of 
N20-NGG, by simply creating a complementary gRNA 15,23,28,29. This form of gene 
editing tool has made it very easy for scientists to study and determine the function of 
specific genes. This type II CRISPR/Cas9 gene editing tool was used in this study to edit 
the promoter of the induced cyclicAMP early repressor (ICER) in zebra fish cells.
Melanoma is a skin cancer that is rapidly growing in western countries. It 
develops in the melanocytes located in the epidermis of the skin32,33. It is caused by 
mutations in B-Raf, N-Ras and H-ras by UV exposure. Mutations, in these proto­
oncogenes, leads to loss of cell cycle control and results in uncontrolled cell proliferation. 
In melanocytes, increased levels of cyclic AMP (cAMP) are observed, which positively 
regulates cell growth and differentiation. Increased levels of cAMP regulate the
10
transcription of many cellular genes. This signaling pathway requires the activation of 
transcription factors by protein kinase A (PKA). PKA phosphorylates many transcription 
factors like CREB (cyclicAMP- response element binding protein), CREM (cyclicAMP -  
response element modulators) and the ATF gene family 32,30,33. Upon phosphorylation 
by PKA, these transcription factors activate CRE-containing genes. CREM is a unique 
gene that generates gene activators and repressors by alternate splicing 30. One of the 
products of the CREM gene that is not activated by PKA is the ICER protein. The CREM 
gene consists of two promoters PI and P2. Both PI and P2 are induced by cAMP 2a 31. 
ICER is a product of P2, which is not regulated by PKA. ICER acts as a potent inhibitor 
of cAMP inducible responses. When the cAMP level increases within a cell, ICER binds 
to CREs on the CREB/CREM gene as a homodimer or heterodimer and negatively down 
regulates cAMP gene expression 31. This function of ICER is important to manage cAMP 
genes, and in keeping the delicate balance that is necessary for proper gene regulation. 
This negative down regulation of ICER prevents the cancer cells from growing in an 
anchorage -  independent manner 30’37. Recent studies have demonstrated that increased 
cAMP levels contribute to melanocyte growth and differentiation, thus resulting in 
melanoma 3 4. In the case of Ras induced melanoma, ICER has been targeted for
degradation by Ras, thereby preventing the down regulation of cAMP genes. This 
indicates the significant role of ICER as a tumor suppressor in preventing melanoma. By 
knocking out the ICER promoter sequence using CRISPR/Cas9 system in zebra fish, it 
may be possible to establish the role of ICER in melanoma.
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Outline of Research and Designing gRNA
The aim of this study was to knock out the ICER gene promoter. The first step 
was to identify the potential target site for gRNA. ZiFiT Targeter 10 was used to identify 
the potential target site for gRNA. This was done by submitting the ICER sequence to 
the ZiFiT website. Out of four suggested target sites, the site that contained part of the 
ICER promoter, with adjacent PAM sequence was selected.
ICER Sequence
CTTCTGAGCTT AAAT A AAT AAAT ATGCAACTGC ACT ATTTTTTT AAGC AATGA
AT AT AAGCTTGT ATGTT AAT AT AAA ATGAGTCCTGTTTCTCTCTCTCTTTC AC A
CACACACACACACACACACACACACACATACATTCTCCAGAGACAGTGTGTT
ATTTCCCTGTGAGGCTGCTGTG ATGTC AT AGTGATGTCAATGCCCTT AATAGT
AATCTGACTGAGCGAGAGAGAGAGGGAGGGAGGGAGGGAGAAAGAGAGAT
AGGGAAGGAGAGAGAGGGTT AAAGGGAAAC AGT AAGTGTC AC AACTCT AAC
AGAGAGTCAGTAGGAGCGCGTGAGAGAGAAACTCAGCCAGCGAAGAGCTGA
AGGG A AG AC AG AGCTTT AAT AGG A A AT C A AG AGG A A AC ACT AT CCC A ACT G
GATT ACT AC AGT AT AG AG ATGGC AGTGACCGGGGAAGA AACCG AGTC AGCT
GCCACAGGAGACATGCCAGCATATCAGATCCGCTCGCCGTCGTCAGGGCTGC
CTCCAGGTGTTGTCATGGCATCGTCACCAGGGGCGATGCACAGCCCGCAACC
CAACGCAGAGGAGGCCACGCGCAAGAGAGAAGTCCGTCTGATGAAGAACAG
GGAGGCAGCGCGCGAGTGTCGCAGAAAAAAGAAAGAATACGTGAAGTGTTT
GGAGAATCGGGTTGCCGTGCTGGAAAACCAGAACAAGACTCTCATAGAGGA
GCTGAAAGCCCTTAAAGACATCTACTGCCACAAGCCTGAATAACCCTCACAA
ACACTGCTCAAGGACTGTGTGATTCACACAATACCCGTCTCCTCACTTCTACT
GCTGCACCGCCTGGATTTT ATCGCT
The sequence in Yellow indicates the gRNA target sequence .The sequence in red color 
(ATG) indicates the start codon.
The research was done in two stages:
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Stage 1- Production of mRNA for in vivo gene alterations study
Two separate vectors, pDR274 and pMLM3613, were used to express gRNA and 
Cas9. Both gRNA and Cas9 sequence were under the control of the T7 promoter.
Previous studies ' suggested that the T7 promoter requires a pair of Guanine or 
Adenine residues at the 5’ end of the transcript. So the gRNA sequence should be in the 
form of 5’-GG/AA-N18-NGG-3’.
The following sequence 5’ -  GGATTACTACAGTATAGA - 3’ was cloned in to 
the vector pDR274. pDR274 harboring the 5’ GGATTACTACAGTATAGA -3’ gRNA 
sequence was transcribed in vitro following the MAXIscript® kit manufacturer’s 
protocol (Life Technologies, Grand Island, NY, USA). Cas9 sequence, under the control 
of theT7 promoter in the vector pMLM3613, was transcribed in vitro following the 
mMessage mMachine T7 ultra kit manufacturer’s protocol ( Life technologies, Grand 
Island, NY, USA). Since Cas9 is an enzyme a 3’ poly (A) tail and a 5’ cap were added to 
the mRNA sequence. The mRNA of both gRNA and Cas9 was purified by lithium 
chloride precipitation and stored.
Stage 2 - In vitro study of CRISPR/Cas9 system in zebra fish cells
A single vector system that carried both gRNA and Cas9 sequences along with 
the sequence for GFP expression was used. This single vector system enhanced the 
chance of equal delivery of all CRISPR/Cas components into the cells. The presence of 
the GFP sequence in the vector made it easy to determine the percentage of transfected 
cells using a fluorescent microscope. When the construct was transfected into the zebra 
fish cells, and if the gRNA bound specifically to the target site, it would direct the Cas9
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nuclease to cleave the target DNA. Cleavage by Cas9 nucleases on the target sequence 
could be determined by amplifying the ICER sequence using PCR and performing a T7 
endonuclease assay on the amplified DNA. A positive result would indicate the 
efficiency of CRISPR/Cas9 system on the ICER sequence in zebra fish. In the future, 
Cas9mRNA and gRNA (generated in stage 1) could be used to perform microinjection in 
zebra fish embryos.
pCMV Cas9GFP(-)atgICER
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pCMVCas9GFP(-)atgICER contains the sequence for gRNA, Cas9 and GFP. U6 
promoter drives gRNA expression and CMV promoter drives Cas9 expression. 
pCMVCas9GFP(-)atgICER was purchased from Sigma (Sigma-Aldrich, St. Louis, MO, 
U SA ).
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Materials and methods
Identifying gRNA target site
The ZiFiT Targeter (http://zifit.partners.org/ZiFiT/) was used to identify the 
potential target site for gRNA. The ZiFiT site also gives the list of oligonucleotide 
sequences necessary for cloning the target sequence into the pDR274 vector.
Target site - 5’ -  GG ATT ACT AC AGT AT AG A - 3’
Oligonucleotide sequence 1 - 5’- TAGG ATT ACT AC AGT AT AG AG A -  3’ 
Oligonucleotide sequence 2 - 5’ -  AAACTCTCTATACTGTAGTAAT -  3’
Stage-1
pDR274atg(-)ICER construction.
E.coli cells containing pDR274 plasmid were purchased from Addgene 
(Cambridge, MA, USA). These bacterial cells were grown on an agar plate containing 
kanamycin, and then plasmid pDR274 was isolated following QIAprep® spin Miniprep 
protocol (Qiagen, Valencia, CA, USA). pDR274 contains the T7 promoter. To this the 
20 nucleotide target sequence (gRNA) was incorporated as following the protocol 
detailed below.
pDR274 digestion and DNA extraction from agarose gel
Ten microliters of pDR274 were mixed with 2 pL of lOx BufferG, 2 pL of Bsal 
(Thermo fisher scientific, Waltham, MA, USA), and 6 pL of double distilled water and 
incubated at 37°C for 1 hour. The reaction mixture was then run on 1% agarose gel at 
100V for 1 hour. The DNA was extracted according to the QIAquick® gel extraction kit
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(Qiagen, Valencia, CA, USA) protocol. The band of interest (approx. 2147bp) was 
excised from the gel, placed in 1.5mL micro centrifuge tube and weighed. To this QC 
buffer was added in the ratio of 1:3 (Gel: QC buffer). The solution was then placed on a 
heating block at 50°C for 10 minutes, mixing every 3 minutes. To this isopropanol was 
added in the ratio of 1:1 (Gel: Isopropanol). The solution was then placed on a DNA 
specific column and purified according to the manufacturer’s protocol. DNA 
concentration was measured with the Nanodrop spectrophotometer.
Ligation of oligonucleotide (gRNA) into pDR274
The forward and reverse oligonucleotides were reconstituted (1.5pg/pL) and were 
mixed together in the ratio of 1:1. The oligonucleotides were annealed by placing them 
in a beaker containing water at 94°C and were then allowed to cool to less than 30°C on 
the bench. Then oligonucleotides were allowed to cool to room temperature overnight. 
Following annealing, different dilutions of inserts (annealed oligos) were prepared (1:5, 
1:10, 1:50, 1:100). DNA ligation was done following manufacturer’s protocol (DNA 
ligation Kit ver. 1 Manual, Takara, Clone Tech Laboratories, Mountain view, CA, USA). 
Five microliters of linearized vector pDR247 (extracted from the gel) was mixed with 
5pL of insert at various concentrations (1:5, 1:10, 1:50 and 1:100). To this 5 0 p L o f 
solution A and 10 pL of solution B were added. The solutions were incubated at 16°C 
for 30 minutes.
DNA transfection and sequencing
DNA transfection was done following One Shot® Top 10 competent cell 
transformation protocol (Invitrogen, Carlsbad, CA, USA). Five microliters of ligate was
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added to 50 pL of One Shot® Top 10 competent cells (1 vial of cells for each dilution). 
The vials were incubated on ice for 20 minutes. Following incubation on ice, the vials 
were incubated in a water bath at 42°C for 30 seconds. Then the vials were immediately 
placed on ice. To this 250 pL of pre-warmed S.O.C medium was added and the vials 
were kept in a shaking incubator for 1 hour at 225RPM. Following transformation, 200 
pL of the mixture from each vial were spread on labeled LB agar plates containing 
kanamycin, and were incubated at 37°C overnight. Following incubation, plasmids were 
isolated from the transfected cells according to the QIAprep® spin Miniprep protocol 
(Qiagen, Valencia, CA, USA). Once the plasmids were isolated, the DNA samples were 
sent to GeneWiz (South Plainfield, NJ, USA) for sequencing to check for the proper 
ligation of target sequence (gRNA) in to pDR274 vector.
In vitro transcription of Cas9mRNA and gRNA
Restriction Digestion of pDR274(-)atgICER and pMLM3613
The expression vector, pMLM3613, containing the gene for Cas9 was purchased 
from Addgene (Cambridge, USA). These bacterial cells were plated on agar dishes 
containing kanamycin. Following incubation, pMLM3613 were isolated from the 
bacterial cells. Both pDR274(-)atgICER and pMLM3613were isolated following 
QIAprep spin Miniprep protocol (Qiagen, Valencia, CA,USA ). Additionally, pDR274(- 
)atgICER was linearized with Dral (Invitrogen, Carlsbad, CA, USA). In a 1.5mL 
microcentrifuge tube, 12 pL of pDR274(-)atgICER, 2 pL lOx buffer B, 1 pL of Dral, and 
5 pL of ultra-pure water were combined and incubated at 37°C for 5 hours. Similarly, 
pMLM3613 was linearized with Pmel (Invitrogen, Carlsbad, CA, USA). In a 1.5mL
17
microcentrifuge tube, 11 pL of pMLM3613, 6 pL ultra-pure water, 2 pL lOXbuffer B 
and 1 ¡iL of Pmel were combined and incubated at 37°C for 5 hours. The digested 
samples were then mixed with 2 pL of loading buffer and run on 1% agarose gel 
(containing ethidium bromide) at 100 volts for 60 minutes in lxTAE buffer. The bands 
were observed under gel dock.
Production of Cas9mRNA and gRNA
The linearized plasmid pDR274(-)atgICER and pMLM3613 were extracted from 
the gel according to the QIAquick® gel extraction kit protocol (Qiagen, Valencia, CA, 
USA), and the concentration of the plasmids were measured with Nanodrop 
spectrophotometer. The linearized plasmids pDR274(-)atgICER and pMLM3613 were 
used as templates for gRNA and Cas9mRNA in vitro transcription. pDR274 (-)atglCER 
was transcribed following MAXIscript® kit manufactures protocol ( Life Technologies, 
Grand Island, NY, USA) . In a 1.5 mL microcentrifuge tube, 80 pL of nuclease free 
water, 10 pL of pDR274(-)atgICER, 2 pL of 10X transcription buffer, 1 pL of 10 mM 
ATP, 10 mM CTP, 10 mM GTP, 10 mM UTP each, 4 pL of T7 (15U/ pL) enzyme were 
added and mixed thoroughly. The solution was incubated at 37°C for 1 hour. Following 
incubation, 1 pL of TURBO DNase (2U/ pL) (Life Technologies, Grand Island, NY, 
USA) was added and incubated at 37°C for 15 minutes.
The expression vector, pMLM3613, was transcribed following the mMessage 
mMachine T7 ultra kit manufacturer’s protocol ( Life Technologies, Grand Island, NY, 
USA). In a 1.5 mL microcentrifuge tube, 20 pL of nuclease free water, 10 pL of T7 2X 
NTP/ARCA, 2 pL of 10X T7 reaction buffer, 6 pL of pMLM3613 and 2 pL of T7 (15U/
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pL ) enzyme were added. The solution was incubated at 37°C for 1 hour. To this, 1 pL of 
TURBO DNase (2U/ pL) was added and incubated for 15 minutes at 37°C. Following 
transcription a 3’poly (A) tail was added according to the of mMessage mMachine® T7 
ultra kit protocol (Life Technologies, Grand Island, NY, USA). To the incubated 
solution, 20 pL of mMessage mMachine® T7 ultra reaction, 36 pL of nuclease free 
water, 20 pL of 5X E — PAP buffer, 10 pL of Mncl2 and 10 pL of ATP solution were 
mixed together. The solution was incubated at 37°C for 40 minutes. After the addition of 
the 3’ poly (A) tail and the 5’ cap, the Cas9mRNA was recovered by lithium chloride 
(LiCl) precipitation and was re-dissolved in RNase free water. The concentration of both 
gRNA and Cas9 mRNA were measured with Nanodrop spectrophotometer.
Stage-2
pCMV Cas9GFP(-)atgICER
The vector, pCMVCas9GFP(-)atgICER ( the gRNA sequence was cloned into the 
vector pCMVCas9GFP by Sigma, to generate pCMVCas9GFP(-)atgICER ) was 
purchased from Sigma (Sigma-Aldrich, St. Louis, MO,USA). The vector contains the 
gRNA, Cas9 and GFP sequence. The gRNA was expressed under the U6 polymerase III 
promoter and Cas9 was expressed under the CMV promoter.
Transfection of pCMVCas9(-)atgICER in PAC-2 cells.
Two PAC-2 cell culture flasks were used. One PAC-2 cell culture flask was 
transfected with pCMVCas9GFP(-)atgICER using FuGENE HD transfection reagent 
(Promega, Madison, WI, USA ) and the other flask was transfected with pCMVEGFP. 
Briefly, 6 pL of pCMVCas9GFP(-)atgICER, 270 pL of LS media and 24 pL of FuGENE
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were combined, and added to the PAC-2 cells. Similarly, 20 pL of pCMVEGFP, 256 pL 
of LS media and 24 pL of FuGENE were combined and added to the second PAC-2 cell 
culture flask. This served as a control. Both the flasks were incubated at 25°C for 48 
hours.
Genomic DNA Extraction
Following 48 hours of incubation and prior to genomic DNA extraction, the cells 
were observed under fluorescent microscope and the transfection efficiency was 
determined. Genomic DNA was extracted using GeneArt ©Genomic cleavage Detection 
Kit (Life technologies, Grand Island, NY, USA). Briefly, the transfected PAC-2 cells 
were washed three times with lmL of 0.1% PBS. After a final wash 500 pL of 0.1%
PBS was added and then the cells were scraped. The cells were then transferred into 
1.5mL centrifuge tube and were centrifuged at 2000 g for 5 minutes at 4°C. The 
supernatant was removed, and to the pellet, 50 pL of cell lysis buffer and 2 pL of protein 
degrader were added and the pellets were re-suspended. The entire solution was then 
transferred into PCR tubes, and cells were lysed in the thermal cycler. The thermal cycler 
parameters for lysis were: 68°C for 15 minutes, 95°C for 10 minutes and 4°C on hold.
Primers Used
ICER SEQUENCE
CTTCTGAGCTT AAAT A AAT AA AT ATGC AACTGC ACT ATTTTTTT AAGC AATGA 
AT AT A AGCTTGT ATGTT AAT AT AAAATG AGTCCTGTTTCTCTCTCTCTTTCAC A 
CACACACACACACACACACACACACACATACATTCTCCAGAGACAGTGTGTT 
ATTT CCCT GTG AGGCTGCT GTG ATGTC AT AGT GAT GT C A AT GCCCTT AAT AGT 
AATCTGACTGAGCGAGAGAGAGAGGGAGGGAGGGAGGGAGAAAGAGAGAT 
AGGGAAGGAGAGAGAGGGTTAAAGGGAAACAGTAAGTGTCACAACTCTAAC
a g a g a g t c a g t a g 1 a g c g c g t g a g a g a 1 a a a c | c a g c c a g c g a a g a 1 c t g a
AGGGAAGACAGAGCTTTAATAGGAAATCAAGAGGAAACACTATCCCAACTG
20
GATT ACT AC AGT AT AG AG ATGGC AGTGACCGGGG A AGA AACCG AGTC AGCT
GCCACAGGAGACATGCCAGCATATCAGATCCGCTCGCCGTCGTCAGGGCTGC
CTCCAGGTGTTGTCATGGCATCGTCACCAGGGGCGATGCACAGCCCGCAACC
CAACGCAGAGGAGGCCACGCGCAAGAGAGAAGTCCGTCTGATGAAGAACAG
GGAGGCAGCGCGCGAGTGTCGCAGAAAAAAGAAAGAATACGTGAAGTGTTT
GGAGAATCGGGTTGCCGTGCTGGAAAACCAGAACAAGACTCTCATAGAGGA
GCTGAAAGCCCTT AAAGAC ATCT ACTGCC AC AAGCCTGAAT AACCCTC AC AA
ACACTGCTCAAGGACTGTGTGATTCACACAATACCCGTCTCCTCACTTCTACT
GCTGCACCGCCTGGATTTTATCGCTCAAA^HHATTGTGCAGGGCCGTfTTGT
TTGTTTGTT
Primers Used
Primer set 1: Forward Primer - AGTAGGAGAGAGTGAGAGAG 
Reverse primer - TAATAATGTGTGCAGGGCCGT
Primer set 2: Forward Primer - GAGCGCGTGAGAGAGAAACT 
Reverse primer - TAATAATGTGTGCAGGGCCGT
Primer set 3: Forward Primer - GAAACTCAGCCAGCGAAGAG 
Reverse Primer -  TAATAATGTGTGCAGGGCCGT
These three sets of primers were used to amplify the ICER sequence.
Yellow sequence - Indicates the target site in ICER sequence where forward primer 1 
anneals in ICER sequence. Red letters -  Indicates the start and end of the target site in 
ICER sequence where primer 2 anneals. Green letters -  The start and end of the target 
site in ICER sequence where forward primer 3 anneals. Purple -  Indicates the target site 
in ICER sequence where reverse primer anneals.
PCR Amplification
Three different sets of primers were designed to amplify the ICER sequence. 
OligoAnalyzer 3.1 (http://www.idtdna.com/analvzer/) was used to design primers for 
PCR. A total of six reactions were prepared. Briefly, 2 pL of genomic DNA, 1 pL of 10 
mM forward primer, 1 pL of 10 mM reverse primer, 25 pL of AmpliTaqGold360 Master 
Mix ( GeneArt ©Genomic cleavage Detection Kit, Life technologies, Grand Island, NY,
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USA) and 22 pL of water were combined together in a PCR tube and PCR reaction was 
run. The thermal cycler parameters were: 95°C for 10 minutes, 40 cycles of 95°C for 30 
seconds, 40 cycles of 55°C for 30seconds, 40 cycles of 72°C for 30 seconds, 72°C for 7 
minutes and 4°C on hold. Three microliters of the PCR product, 1.3 pL of lOx loading 
buffer and 10 pL of water were combined in a PCR tube and were run on a 2% agarose 
gel. Five microliters of DNA ladder (HiLo, Minnesota Molecular Inc, MN, USA) was run 
in parallel to compare and estimate the fragment size and DNA concentration of the 
products.
Cleavage Assay
The amplified PCR samples were subjected to a cleavage assay. This was done 
following the GeneArt® Genomic Cleavage Detection Kit (Life technologies, Grand 
Island, NY, USA). Briefly, 3 pL of PCR product, 1 pL of detection reaction buffer and 5 
pL of water were combined in a PCR tube. These solutions were then kept in the thermal 
cycler for re-annealing. The thermal cycler parameters are: 95°C for 5min, 95°C to 85°C 
at the rate of (-2°C)/seconds, 85°C to 25°C at the rate of (-0.1 °C)/seconds, 4°C on hold. 
Following re-annealing, 1 pL of detection enzyme was added to the entire mixture and 
the samples were incubated in a water bath at 37°C for 1 hour.
Agarose gel electrophoresis
Following enzyme digestion, to each enzyme digested sample, 10 pL of water and 
2 pL of lOx loading buffer were added. The samples were then run on a 2% agarose gel 
at lOOv for 60 minutes. Five microliters of DNA ladder (HiLo, Minnesota Molecular Inc, 
MN, USA) was run in parallel to compare the size of the cleaved products.
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Results
Stagel
Inserting gRNA sequence into pDR274/ construction of pDR274(-)atgICER
The goal of this project was to knockout the ICER promoter by using a gRNA 
specifically targeting the ICER promoter sequence followed by the cleavage of Cas9. In 
order to produce the vector, pDR274(-)atgICER, plasmid pDR274 was linearized and 
analyzed by agarose gel electrophoresis. The band of size 2147 (Figure 1) was excised 
and pDR274 was extracted. The concentration of the plasmid was measured with the 
NanoDrop spectrophotometer. The total yield of pDR274 was 200 ng/pL. This pDR274 
was ligated with gRNA oligonucleotides and the constructs were transfected. The 
plasmids extracted from the transfected cells were sequenced. The sequenced data 
suggest the successful insertion of gRNA into pDR274. The inserted gRNA 
oligonucleotide is highlighted in yellow (Figure 2).
In vitro transcription of Cas9mRNA and gRNA
The vector, pDR274(-)atgICER, was digested and analyzed by agarose gel 
electrophoresis. Two bands of approximate size 1885 bp and 282 bp were observed 
(Figure 3). The band of size 282 bp that contained the gRNA sequence was excised for 
DNA extraction. The concentration of the DNA was measured with a Nanodrop 
spectrophotometer and the yield was 1 pg/pL. The extracted DNA was transcribed into 
RNA and concentration was measured. The total yield of gRNA was 634.2 ng/pL.
The vector, pMLM3613 was digested and the band of size 8000 bp was extracted 
(Figure 2) and the concentration of the DNA was measured. The total yield was 2.2
23
^xg/^ iL. The extracted DNA was transcribed into RNA and the RNA concentration was 
measured. The yield of Cas9mRNA was 1 pg/pL. The RNA was analyzed by a RNA gel 
electrophoresis (Figures 4a and 4b).
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2000bp - -pDR274
Figure 1 - Lane 1-Molecular weight marker (HiLo). Lanes 2 and 3 - pDR274 (-2147) 
digested with Bsal.
CCCGTGTAAAACGACGGCCAGTTTATCTAGTCAGCTTGATTCTAGCTGATCGTGGACCGGAAGGTGAGCC
AGTGAGTTGATTGCAGTCCAGTTACGCTGGAGTCTGAGGCTCGTCCTGAATGATATGCGACCGCCGGAGG
GTTGCGTTTGAGACGGGCGACAGATCCAGTCGCGCTGCTCTCGTCGATCCAAGCTTTTTAAAAGCACCGA
CTCGGTGCC ACTTTTTC A AGTTGATAACGGACT AGCCTT ATTTT A ACTTGCT ATTTCT AGCTCTA
TAGGATTACTACAGTATAGAGACCTATAGTGAGTCGTATTAGCTAGCGGTGCGAGCGGATCGAGCAGTGTCG
ATCACTACTGGACCGCGAGCTGTGCTGCGACCCGTGATCTTACGGCATTATACGTATGATCGGTCCACGA
TCAGCTAGATTATCTAGTCAGCTTGATGTCATAGCTGTTTCCTGAGGCTCAATACTGACCATTTAAATCA
TACCTGACCTCCATAGCAGAAAGTCAAAAGCCTCCGACCGGAGGCTTTTGACTTGATCGGCACGTAAGAG
GTTCCA ACTTTC ACCAT A ATG A A ATA AGATC ACTACCGGGCGT ATTTTTTGAGTT ATCGAGATTTTC AGG
AGCTAAGGAAGCTAAAATGAGCCATATTCAACGGGAAACGTCTTGCTTGAAGCCGCGATTAAATTCCAAC
ATGGATGCTGATTTATATGGGTATAAATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACAATCTATC
GATTGTATGGGAAGCCCGATGCGCCAGAGTTGTTTCTGAAACATGGCAAAGGTAGCGTTGCCAATGATGT
TACAGATGAGATGGTCAGGCTAAACTGGCTGACGGAATTTATGCCTCTTCCGACCATCAAGCATTTTATC
CGTACTCCTGATGATGCATGGTTACTCACCACTGCGATCCCAGGGAAAACAGCATTCCAGGTATTAGAAG
AATATCCTGATTCAGGTGAAAATATTGTTGATGCGCTGGCAGTGTTCCTGCGCCGGTTGCATTCGATTCC
TGTTTGTAATTGTCCTTTTAACGGCGATCGCGTATTTCGTCTCGCTCAGGCGCAATCACGAATGAATAAC
GGTTTGGTTGGTGCGAGTGATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAAGAAA
Figure 2 - Confirmation of gRNA sequence in pDR274 vector. Yellow highlights the 
gRNA sequence.
1 2 3 4 5 6 7 8 9  10
Figure 3 - Lane 1- molecular weight (HiLo), Lanes 2-6 -  pMLM3613 digested with 
Pmel and the band displays the successfully linearized plasmid. Lanes 7-10 -  pDR274(- 
)atgICER digested with Dral sample and displays 2 distinct bands. The band ~ 282 bp 
codes for gRNA sequence.
Figure 4a - Cas9mRNA and gRNA were transcribed in vitro and was run on RNA gel. 
Lane 1- Molecular weight 0.5,1,1.5,2,2.5,3,4,5,6 and 9kb, Lane-2— Cas9RNA after 
poly(A) tail, Lane-3—Cas9 RNA before poly(A) addition, Lane-4 -  gRNA (the band is 
faint).
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Figure 4b - Cas9mRNA and gRNA were transcribed in vitro and was run on RNA gel. 
Lane 1- Molecular weight 0.5,1,1.5,2,2.5,3,4,5,6 and 9kb, lane-2— Cas9RNA after 
addition of poly(A) tail and smeared band was observed, Lane-3— Cas9 RNA before 
poly(A) addition, Lane-4 -  gRNA band is not visible.
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Stage -2
Transfection of PAC-2 cell line with pCMVCas9GFP(-)atgICER and pCMVEGFP
The transfected cells were observed under a fluorescent microscope. The 
percentage of transfection was determined by counting the total number of cells and the 
number of cells that emitted fluorescence. The percentage of transfection in the control 
flask (PAC-2 cells transfected with pCMVEGFP) and the test flask (PAC-2 cells 
transfected with pCMVCas9GFP (-)atglCER) was 14.2% and 8.7%, respectively 
(Figures 5a and 5b). Overall, the transfection efficiency was very low in both test and 
control flasks.
Table 1 - Percentage of Transfection in PAC-2 cells
PAC-2 Cells 
Transfected plasmid
Total Number 
of cells
Fluorescent
cells
%
Transfection
pCMVCas9GFP(-)atgICER 114 10 8.7
pCMVEGFP 140 20 14.2
Genomic DNA Extraction and Amplification of ICER
Total genomic DNA was extracted from test (PAC-2 cells transfected with 
pCMVEGFP) and control (PAC-2 cells transfected with pCMVCas9GFP(-)atgICER) 
cells. The ICER sequence was amplified with PCR. Gel electrophoresis of PCR products 
gave a strong band of size 350 bp with all 3 sets of primers (Figure 6).
Cleavage Assay
The PCR products were cleaved with detection enzymes and were analyzed by 
agarose gel electrophoresis. The bands obtained in each lane were compared with a
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positive control. Samples amplified with primer set 1 and primer set 2 did not have three 
bands as was visible in the positive control. The samples amplified with primer set 3, had 
three bands similar to that of the positive control (Figure 7). This indicates that the 
cleavage assay was successful and the ICER promoter sequence was knocked out. The 
cleavage band that appeared in lane 3(+) was very faint. This suggests that the 
transfection efficiency had a major effect on the band strength since only 8% of cells 
were transfected.
29
5a 5b
Figure 5a - Control- PAC-2 cells transfected with pCMVEGFP (viewed under 
fluorescent microscope -  400x).
Figure 5b - Test- PAC- 2 cells transfected with pCMVCas9GFP (-)atglCER (viewed 
under fluorescent microscope -  400x).
MW l(-) l(+ï 2(~) 2(+) 3(-J 3(+) +C
Figure 6 - Gel display the PCR amplification. The band of ~350bp indicates that the 
ICER sequence has been amplified, l(-) and 1(+) indicates PCR amplification with 
primer set 1. 2(-) and 2(+) indicates PCR amplification with primer set 2. 3(-) and 3(+) 
indicates PCR amplification with primer set 3. +C indicates positive control (sample from 
the gene art kit)
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MW l(-) 1(+) 2{~) 2(+) 3{-) 3{+) +C
cleavage band 1 
. cleavage band 2
Figure 7- Gel displays the cleavage assay. Lane l(-) and 1(+), Lane 2(-) and 2(+) 
displays one band. This indicates that the cleave assay is not positive and ICER promotes 
sequence is not cleaved. Lane 3(+) displays cleavage bands similar to that of the +C, and 
the 2nd cleavage band is visible, but it is very faint.
31
Discussion
The vector pCMVCas9GFP(-)atgICER successfully knocked out the ICER 
promoter sequence in vitro, in PAC-2 cell lines. At the same time, the cleavage bands 
obtained, after the cleavage assay, were not very strong. One of the major reasons behind 
this was the transfection efficiency in PAC-2 cell lines. The percentage of transfection in 
the PAC-2 cell line with a ratio of 8:2 was only 3% and the cleavage assay result was not 
positive. In an attempt to increase the transfection efficiency, a ratio of 10:2 was used, 
and the percentage of transfection was increased by 5.2%. The cleavage assay was 
successful, but the cleavage bands were very faint. The other factor that would have had 
an effect on the cleavage assay was the percentage of indels formed. It was demonstrated 
that indel mutation less than 2% at the target site will not be cleaved by cleavage 
enzymes L\  Since the overall transfection in PAC-2 cells was only 8.2%, it could have 
had a major effect in the percentage of indels formed. The other factor that might have 
had an effect on the cleavage assay results was the specificity of Cas9 nucleases. Cas9 
cleaves the target at the PAM site, and acts efficiently if the PAM sequence is NGG. The 
PAM site at the 3’end of the gRNA used in this research is NGA and this might have 
reduced the specificity of Cas9.
The other major challenge in this research was to produce a sufficient amount of 
gRNA by in vitro transcription. The initial concentration of gRNA after in vitro 
transcription was around 43.2 ng/pL. It was believed that lithium chloride worked better 
on RNA samples greater than 300 bp and the gRNA used in this research was only 282 
bp. In an attempt to increase the gRNA yield, the gRNA was transcribed in vitro again 
and the RNA was precipitated with ammonium acetate. The gRNA yield increased and
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the concentration of gRNA was around 634.2 ng/pL. This gRNA concentration should be 
sufficient to perform in vivo experiment in zebra fish embryos.
Future Studies
In the future, the gRNA and Cas9mRNA generated in vitro could be used to 
perform an in vivo transfection in zebra fish embryos. While performing the 
microinjection, it would be good to try various concentrations of gRNA and Cas9mRNA, 
since the difference in concentrations may have an impact in the percentage of indel 
formations 2\  Future studies should also concentrate on the factors that affect the 
transfection efficiency and Cas9 nuclease’s specificity. It is necessary to optimize the 
transfection in PAC-2 cells by trying different transfection ratios. A few recent studies 
have demonstrated nucleofection as the better transfection method for PAC-2 cell lines ’ 
36. If possible, transfection efficiency in PAC-2 cells could be studied using different 
transfecting reagents, and the reagent that gives better efficiency could be used in future 
research. Since in this research the bands obtained after the cleavage assay were very 
faint, the DNA sequencing should be done on the PCR products to confirm the presence 
of an indel mutation in the target sequence. Since there is a possibility that NAG located 
next to the 3’ end of the gRNA at the target site might have had an effect on Cas9 
cleavage, in the future, designing a gRNA that satisfies the NGG requirement next to the 
3’end may give better results. This could be achieved by extending the current gRNA by 
3 bases at the 3’end.
These suggested changes, especially optimizing the transfection efficiency and 
increasing Cas9 specificity, may increase the effect of CRISPR/Cas9 system in knocking
33
out the ICER promoter sequence in zebra fish cells (in vitro) and in zebra fish embryos 
(in vivo). Knocking out the ICER promoter sequence in zebra fish models may establish 
the tumorigenicity of ICER in melanomas.
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